Brazil To Break Patent On Abbott Drug In Ten Days

Law360, New York (July 1, 2005, 12:00 AM EDT) -- Brazil has informed Abbott Laboratories that it will break the company's patent on the antiretroviral drug Kaletra in the next few days unless the U.S. drug maker offers a steep price break on the HIV/AIDS drug.

Brazilian Health Minister Humberto Costa said the government would break the patent within 10 days unless the company lowers the price of the drug 42% to $1.17 per pill, according to the Financial Rimes.

If the patent is broken, generic drug manufacturers could begin producing versions of the drug, which...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.